Proteasome Inhibitor-Induced Modulation Reveals the Spliceosome as a Specific Therapeutic Vulnerability in Multiple Myeloma

Nature Communications - United Kingdom
doi 10.1038/s41467-020-15521-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma

Cancer Cell
Cancer ResearchOncologyCell Biology
2013English

Proteasome and Heat Shock Protein 70 (HSP70) Inhibitors as Therapeutic Alternative in Multiple Myeloma

Oncotarget
Oncology
2017English

Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Sensitizing Human Multiple Myeloma Cells to the Proteasome Inhibitor Bortezomib by Novel Curcumin Analogs

International Journal of Molecular Medicine
MedicineGenetics
2011English

Investigating Effects of Proteasome Inhibitor on Multiple Myeloma Cells Using Confocal Raman Microscopy

Sensors
InstrumentationInformation SystemsElectronic EngineeringBiochemistryAnalytical ChemistryMolecular Physics,ElectricalAtomicMedicineOptics
2016English

A Metabolic Switch in Proteasome Inhibitor-Resistant Multiple Myeloma Ensures Higher Mitochondrial Metabolism, Protein Folding and Sphingomyelin Synthesis

Haematologica
Hematology
2019English

P27Kip1in Proteasome Inhibitor-Induced Apoptosis

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2003English

Novel Strategies to Target the Ubiquitin Proteasome System in Multiple Myeloma

Oncotarget
Oncology
2015English

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy